2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of pax5 in lipopolysaccharide-activated B cells

Toxicological Sciences

Volumn 77, Issue 2, 2004, Pages 272-279

  Yoo, Byung S ^a,c   Boverhof, Darrel R ^b   Shnaider, Dina ^a,b   Crawford, Robert B ^a   Zacharewski, Timothy R ^b   Kaminski, Norbert E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Kyonggi University   (South Korea)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; B cell; Immunoglobulin heavy chain; Immunoglobulin kappa light chain; Pax5; X box binding protein 1

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; MESSENGER RNA; TRANSCRIPTION FACTOR PAX5;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOTOXICITY; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA CELL; PROTEIN EXPRESSION;

ANIMALS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOWN-REGULATION; ENVIRONMENTAL POLLUTANTS; IMMUNOGLOBULINS; LIPOPOLYSACCHARIDES; MICE; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTORS;

EID: 1342310158     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh013     Document Type: Article

References (32)

1. Adams, B., Dorfler, P., Aguzzi, A., Kozmik, Z., Urbanek, P., Maurer-Fogy, I., and Busslinger, M. (1992). Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6, 1589-1607.
2. Arnold, L. W., LoCascio, N. J., Lutz, P. M., Pennell, C. A., Klapper, D., and Haughton, G. (1983). Antigen-induced lymphomagenesis: Identification of a routine B cell lymphoma with known antigen specificity. J. Immunol. 131, 2064-2068.
3. Bishop, G. A., and Haughton, G. (1986). Induced differentiation of a transformed clone of Ly-1 + B cells by clonal T cells and antigen. Proc. Natl. Acad. Sci USA 83, 7410-7414.
4. Calfon, M., Zeng, H., Urano, F., Till, J. H., Hubbard, S. R., Harding, H. P., Clark, S. G., and Ron, D. (2002). IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415, 92-69.
5. kip1 in lipopolysaccharide-activated B cells. Toxicol. Sci. 75, 333-342.
6. Dooley, R. K., and Holsapple, M. P. (1988). Elucidation of cellular targets responsible for tetrachlorodibenzo-p- dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte. Immunopharmacology 16, 167-180.
7. Herring, A. C., and Kaminski, N. E. (1999). Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes. J. Pharmacol. Exp. Ther. 291, 1156-1163.
8. Horcher, M., Souabni, A., and Busslinger, M. (2001). Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14, 779-790.
9. Kozmik, Z., Wang, S., Dorfler, P., Adams, B., and Busslinger, M. (1992). The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell Biol. 12, 2662-2672.
10. Luster, M. I., Germolec, D. R., Clark, G., Wiegand, G., and Rosenthal, G. J. (1988). Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J. Immunol. 140, 928-935.
11. Maitra, S., and Atchison, M. (2000). BSAP can repress enhancer activity by targeting PU.1 function. Mol. Cell Biol. 20, 1911-1922.
12. McKercher, S. R., Torbert, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., and Maki, R. A. (1996). Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. Embo. J. 15, 5647-5658.
13. Morris, D. L., and Holsapple, M. P. (1991). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation. Immunopharmacology 21, 171-181.
14. Morris, D. L., Karras, J. G., and Holsapple, M. P. (1993). Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells. Immunopharmacology 26, 105-112.
15. Neurath, M. F., Max, E. E., and Strober, W. (1995). Pax5 (BSAP) regulates the murine immunoglobulin 3′ alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Proc. Natl. Acad. Sci. USA 92, 5336-5340.
16. Neurath, M. F., Strober, W., and Wakatsuki, Y. (1994). The murine Ig 3′ alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP). J. Immunol. 153, 730-742.
17. Nutt, S. L., Eberhard, D., Horcher, M., Rolink, A. G., and Busslinger, M. (2001). Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int. Rev. Immunol. 20, 65-82.
18. Nutt, S. L., Urbanek, P., Rolink, A., and Busslinger, M. (1997). Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11, 476-491.
19. Reimold, A. M., Iwakoshi, N. N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, E. M., Friend, D., Grusby, M. J., Alt, F., and Glimcher, L. H. (2001). Plasma cell differentiation requires the transcription factor XBP-1. Nature 412, 300-307.
20. Reimold, A. M., Ponath, P. D., Li, Y. S., Hardy, R. R., David, C. S., Strominger, J. L., and Glimcher, L. H. (1996). Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183, 393-401.
21. Rinkenberger, J. L., Wallin, J. J., Johnson, K. W., and Koshland, M. E. (1996). An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 5, 377-386.
22. Roque, M. C., Smith, P. A., and Blasquez, V. C. (1996). A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3′ enhancer. Mol. Cell Biol. 16, 3138-3155.
23. Scott, E. W., Simon, M. C., Anastasi, J., and Singh, H. (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577.
24. Shen, X., Ellis, R. E., Lee, K., Liu, C. Y., Yang, K., Solomon, A., Yoshida, H., Morimoto, R., Kurnit, D. M., Mori, K., and Kaufman, R. J. (2001). Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 107, 893-903.
25. Sulentic, C. E., Holsapple, M. P., and Kaminski, N. E. (1998). Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8- tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol. Pharmacol. 53, 623-629.
26. Sulentic, C. E., Holsapple, M. P., and Kaminski, N. E. (2000). Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J. Pharmacol. Exp. Ther. 295, 705-716.
27. Tucker, A. N., Vore, S. J., and Luster, M. I. (1986). Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 29, 372-377.
28. Urbanek, P., Fetka, I., Meisler, M. H., and Busslinger, M. (1997). Cooperation of Pax2 and Pax5 in midbrain and cerebellum development. Proc. Natl. Acad. Sci USA 94, 5703-5708.
29. Usui, T., Wakatsuki, Y., Matsunaga, Y., Kaneko, S., Koseki, H., Kita, T., and Kosek, H. (1997). Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. J. Immunol. 158, 3197-3204.
30. Vorderstrasse, B. A., Steppan, L. B., Silverstone, A. E., and Kerkvliet, N. I. (2001). Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol. Appl. Pharmacol. 171, 157-164.
31. Williams, C. E., Crawford, R. B., Holsapple, M. P., and Kaminski, N. E. (1996). Identification of functional aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator in murine splenocytes. Biochem. Pharmacol. 52, 771-780.
32. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., and Mori, K. (2001). XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881-891.